Apple stock slips today as Apple Card shifts to JPMorgan, payrolls and earnings loom
8 January 2026
2 mins read

Apple stock slips today as Apple Card shifts to JPMorgan, payrolls and earnings loom

New York, Jan 8, 2026, 09:34 EST — Regular session

  • Apple shares down 0.8% in early trade, lagging recent megacap churn
  • Apple and JPMorgan say Chase will become the new Apple Card issuer in about 24 months
  • Focus turns to Friday’s U.S. jobs report and Apple’s Jan. 29 earnings call

Apple (AAPL.O) shares slid 0.8% to $260.33 in early trading on Thursday. The stock closed at $262.32 on Wednesday.

The move keeps attention on Apple’s services and payments push, a piece of the story that tends to matter more when hardware demand looks harder to read. Investors have also started treating big-tech leadership as less stable than it looked a few months ago.

The broader tape was cautious ahead of Friday’s U.S. nonfarm payrolls report, after data this week pointed to slower hiring even as layoffs stayed relatively low. “Both data points ended up pointing to a softening in the job picture,” Sam Stovall, chief investment strategist at CFRA Research, said. Alphabet (GOOGL.O) overtook Apple in market value on Wednesday for the first time since 2019, a reminder that the market’s pecking order can change quickly. 1

Apple and Chase said Chase will become the new issuer of Apple Card, with a transition expected in about 24 months, and Mastercard will remain the payment network. “We’re incredibly proud of how Apple Card has transformed the credit card experience for customers,” said Jennifer Bailey, Apple’s vice president of Apple Pay and Apple Wallet. JPMorgan said the portfolio is estimated to bring over $20 billion of card balances to the Chase platform and that it expects a $2.2 billion provision for credit losses — money set aside for potential loan defaults — tied to the forward purchase commitment. 2

The agreement still needs regulatory approval and is not expected to close for roughly two years. Goldman CEO David Solomon said the deal “substantially completes the narrowing of our focus in our consumer business,” as the bank continues to unwind its retail push. Goldman also said the transaction is expected to add about 46 cents per share to its fourth-quarter 2025 earnings, mainly due to the release of $2.48 billion in loan-loss reserves, partly offset by a $2.26 billion hit to net revenue. 3

Apple’s next checkpoint is earnings, where investors typically press on iPhone demand and the pace of services growth. The company last reported quarterly revenue of $102.5 billion, up 8% year over year, with diluted earnings per share of $1.85, and said services revenue reached a new all-time high. 4

But the Apple Card handoff is a long runway, and delays or surprises on credit losses could complicate a transition that still has to clear regulators. Apple has said there will be no immediate changes for cardholders, and key features such as cash-back rewards and the high-yield savings account linked to the card will remain. 5

Next for traders is Friday’s U.S. jobs report, then Apple’s quarterly conference call on Jan. 29 at 5 p.m. ET. Any shift in tone on consumer spending and services momentum is likely to drive the next leg for AAPL. 6

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Nokia Oyj stock slides in Helsinki as Kepler upgrade bounce fades ahead of Jan. 29 results
Previous Story

Nokia Oyj stock slides in Helsinki as Kepler upgrade bounce fades ahead of Jan. 29 results

Mobileye stock falls as $900 million humanoid-robot deal meets a reality check
Next Story

Mobileye stock falls as $900 million humanoid-robot deal meets a reality check

Go toTop